Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-002136
Filing Date
2025-01-27
Accepted
2025-01-27 16:49:49
Documents
1
Period of Report
2025-01-23

Document Format Files

Seq Description Document Type Size
1 form4-01272025_090146.html 4  
1 form4-01272025_090146.xml 4 5776
  Complete submission text file 0001415889-25-002136.txt   7195
Mailing Address 132 PURDURE AVENUE KENGSINGTON CA 94708
Business Address
BJERKHOLT ERIC (Reporting) CIK: 0001197350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38981 | Film No.: 25559768

Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Issuer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)